THE IN VITRO AND EX VIVO EFFECT OF PHYLLANTHUS NIRURI METHANOL EXTRACT ON HEPATIC UDP-GLUCURONYLTRANSFERASE ENZYME ACTIVITY IN STZ-INDUCED DIABETIC SPRAGUE DAWLEY RATS
Objective: The aim of the study was to investigate the in vitro and ex vivo (acute and sub-chronic doses) effect of Phyllanthus niruri methanol extract (PNME) on the microsomal UDP-glucuronyltransferase (UGT) enzyme activity in streptozotocin (STZ)-induced diabetic young female Sprague Dawley (SD) rats.
Methods: Young female SD rats were induced type I diabetes mellitus using STZ (60 mg/kg i. v.). The in vitro study was performed on a microsomal fraction of diabetic rat livers using PNME in doses of (0.01 µg, 1 µg and 10 µg)/ml. While ex vivo studies were performed on the microsomal fraction of diabetic rats using PNME in doses of 500, 1000, 2000 and 5000 mg/kg p. o. for acute ex vivo study (one-day treatment) and 100, 500 and 2000 mg/kg/day p. o. for sub-chronic one (daily dose for two weeks). p-nitrophenol (p-NP), was used as a marker substrate for UGT enzyme activity and analyzed using the spectrophotometer to determine UGT enzyme activity.
Results: The in vitro result showed that, there is no significant effect of the three concentrations of PNME versus control on UGT activity in the microsomal fraction of diabetic young female SD rat livers, while for ex vivo study, the result showed that UGT activity in the microsomal fraction of diabetic young female SD rats significantly and dose-independently increased at doses 1000, 2000 and 5000 mg/kg p. o in acute study (all p<0.05 vs control). However, no significant effect of PNME has been seen in the three doses used in the sub-chronic study.
Conclusion: The three different concentrations of PNME have no significant effect as compared to control on UGT activity in the in vitro study. However, ex vivo study showed significant and dose-independent increased in UGT activity at doses 1000, 2000, and 5000 mg/kg p. o in acute study (all P<0.01 vs control), but no significant effect on sub-chronic study.
2. Notka F, Meier G, Wagner R. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res 2004;64:93-102.
3. Barros ME, Schor N, Boim MA. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res 2003;6:374-9.
4. Kassuya CA, Silvestre A, Jr M-D-L O, Marotta DM, Rehder VL, Calixto JB. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor. Eur J Pharmacol 2006;546:182-8.
5. Khanna AK, Rizvi F, Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol 2002;82:19-22.
6. Lin SY, Wang CC, Lu YL, Wu WC, Hou WC. Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria. Food Chem Toxicol 2008;46:2485-92.
7. Kolodziej H, Burmeister A, Trun W, Radtke OA, Kiderlen AF, Ito H, et al. Tannins and related compounds induce nitric oxide synthase and cytokines gene expressions in Leishmania major-infected macrophage-like RAW 264.7 cells. Bioorg Med Chem 2005;13:6470-6.
8. Kloucek P, Polesny Z, Svobodova B, Vlkova E, Kokoska L. Antibacterial screening of some peruvian medicinal plants used in callería district. J Ethnopharmacol 2005;99:309-12.
9. Murugaiyah V, Chan KL. Antihyperuricemic lignans from the leaves of Phyllanthus niruri. Planta Med 2006;72:1262-7.
10. Calixto JB, Santos AR, Cechinel Filho V, Yunes RA. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med Res Rev 1998;18:225-58.
11. Liska DJ. The Detoxification enzyme systems. Altern Med Rev 1998;3:187-98.
12. Dutton GJ. Glucuronidation of drugs and other compounds. Boca Raton: CRC Press; 1980.
13. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997;7:255-69.
14. Burchell B. Transformation reactions: Glucuronidation. Woolf TF. Handbook of Drug Metabolism. New York: Marcel Dekker Inc; 1999.
15. Ritter JK. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 2000;129:171-93.
16. Turgeon D, Carrier JS, Levesque E, Beatty BG, Belanger A, Hum DW. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 2000;295:489-504.
17. Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol 2003;38:107-17.
18. Mohamed MEF, Frye RF. Effects of herbal supplements on drug glucuronidation. Review of Clinical, Animal, and In vitro studies. Planta Med 2011;77:311-21.
19. Chavez ML, Jordan MA, Chavez PI. Evidence-based drug-herbal interactions. Life Sci 2006;78:2146-57.
20. Zhou SF, Zhou ZW, Li CG, Chen X, Yu XY, Xue CC, et al. Identification of drugs that interact with herbs in drug development. Drug Discovery Today 2007;12:664-73.
21. Bashir MK. Effect of standardised methanolic extract of Phyllanthus niruri (LINN.) on phase I and phase II drug metabolism and its molecular mechanism elucidation in rat liver [PhD thesis]. Penang: Universiti Sains Malaysia; 2010.
22. Murugaiyah V, Chan KL. Determination of four lignans in Phyllanthus niruri L. by a simple high-performance liquid chromatography method with fluorescence detection. J Chromatogr A 2007;1154:198-204.
23. Rooseboom M, Vermeulen NPE, Groot EDJ, Commandeur JNM. Tissue distribution of cytosolic B-elimination reactions of selenocysteine Se-conjugates in rat and human. Chem Biol Interact 2002;140:243-64.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
25. Bock KW, Burchell B, Dutton GJ, Hanninen O, Mulder GJ, Owens IS, et al. UDP-glucuronyltransferase activities guidelines for consistent interim terminology and assay conductions. Biochem Pharmacol 1983;32:953-5.
26. Embola CW, Sohn OS, Fiala ES, Weisburger JH. Induction of UDP-glucuronyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem Toxicol 2002;40:841-4.
27. Han CJ. Drug metabolism and toxicity studies of Orthosiphon stamineus, Benth (Misai Kucing) in rats [PhD thesis]. Penang: Universiti Sains Malaysia; 2006.
28. Green MD, Tephly TR. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos 1996;24:356-63.
29. Burchell B, Coughtrie WH. Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation. Environ Health Perspect 1997;105:739-47.
30. Berg CL, Radomiska A, Lester R, Gollan JL. Membrane translocation and regulation of uridine diphosphate-glucuronic acid uptake in rat liver microsomal vesicles. Gastroenterology 1995;108:183-92.
31. Bossuyt X, Blanckaert N. Mechanism of stimulation of microsomal UDP-glucuronosyltransferase by UDP-N-acetylglucosamine. Biochem J 1995;305:321-8.
32. Ikushiro S, Emi Y, Iyanagi T. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 1997;36:7154-61.
33. Vega P, Gaule C, Mancilla J, Del Villar E. Comparison of alloxan and streptozotocin induced diabetes in rats: differential effects on microsomal drug metabolism. Gen Pharmacol 1993;24:489-95.
34. Maliakal PP, Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol 2001;53:1323-9.
35. Turesky RJ, Richoz J, Constable A, Curtis KD, Dingley KH, Turteltaub KW. The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Chem Biol Interact 2003;145:251-65.
36. Lhostea EF, Glouxa K, De Waziersb I, Garridoa S, Lorya S, Philippea C, et al. The activities of several detoxication enzymes are differentially induced by juices of garden cress, water cress and mustard in human HepG2 cells. Chem Biol Interact 2004;150:211-9.
37. Tepsuwan A, Kupradinun P, Kusamran WR. Effect of siamese cassia leaves on the activities of chemical carcinogen metabolizing enzymes and on mammary gland carcinogenesis in the rat. Mutat Res 1999;428:363-73.
38. Bonzo JA, Bélanger A, Tukey RH. The role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice. Hepatology 2007;45:349-60.
39. Li L, Stanton JD, Tolson AH, Luo Y, Wang H. Bioactive terpenoids and flavonoids from ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X Receptor, Constitutive androstane Receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 2008;26:872-82.
40. Kiang TK, Ensom MH, Chang TK. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 2005;106:97-132.
41. Talalay P. The role of enzyme induction in protection against carcinogenesis. Wattenberg LW, Lipkin M, Boone CW, Kelloff GJ. Cancer Chemoprevention. Boca Raton: CRC Press; 1992.
42. Xie W, Yeuh M, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 2003;100:4150-5.
43. Kundu R, Dasgupta S, Biswas A, Bhattacharya A, Pal BC, Bandyopadhyay D, et al. Cajanus cajan Linn. (Leguminosae) prevents alcohol-induced rat liver damage and augments cytoprotective function. J Ethnopharmacol 2008;118:440-7.